As of April, the pace of inflation has slowed from a year-over-year peak of 9.1% to 5%. That's good news for struggling consumers, but doesn't tell the whole story of how much more Americans are ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

2021 was another remarkable and demanding year for the Transparency International movement. As the pandemic continued to disrupt and reshape global affairs, our international secretariat, chapters and ...

How Many Deaths Did COVID-19 Cause in 2021? COVID-19 was the third-leading cause of death in the U.S. last year, according to data from the Centers for Disease Control and Prevention. It’s the second ...

The COVID-19 pandemic set off nearly unprecedented churn in the U.S. labor market. Widespread job losses in the early months of the pandemic gave way to tight labor markets in 2021, driven in part by ...

Super Bowl LVI's in the books, ending the longest season in NFL history. How did the new guys perform in the expanded 285-game slate? Over the past couple weeks, NFL.com rolled out ...

Two years into the devastating COVID-19 pandemic, this year’s Corruption Perceptions Index (CPI) reveals that corruption levels remain at a standstill worldwide. Despite commitments on paper, 131 ...

Music contains so many multitudes that sweeping generalizations about it rarely ring true, but this one still does: There are few things more exciting than an excellent debut album. It’s a thrill to ...

The term "game manager" used to describe mediocre quarterbacks who didn't make mistakes. Now the two best quarterbacks of the season -- and the last decade -- are the ultimate game managers. Back in ...

The FDA approved 50 novel drugs in 2021, including the first KRAS inhibitor for cancer and the first anti-amyloid antibody for Alzheimer’s disease. The FDA’s approval count last year was in line with ...